• FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • Hrv
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations

Pharmacovigilance

  • Homepage
  • Pharmacovigilance
  • New Safety Information

Meeting highlights from the PRAC meeting in February 2017

13.02.2017

more

EMA to review persistence of side effects known to occur with quinolone and fluoroquinolone antibiotics

13.02.2017

more

PRAC concludes that diabetes medicine canagliflozin may contribute to risk of toe amputation

13.02.2017

more

Meeting highlights from the CMDh meeting in January 2017

03.02.2017

more

Meeting highlights from the CHMP meeting in January 2017

01.02.2017

more

Meeting highlights from the PRAC meeting in January 2017

13.01.2017

more

Direct healthcare professional communication on the risk of medication errors associated with overdosing with medicinal products containing levetiracetam oral solution (Keppra 100 mg/ml oral solution)

03.01.2017

more

  • «
  • 1
  • 2
  • 3

For Patients and Public

For Health Care Professionals

For Industry Representatives

  • What is Pharmacovigilance?
  • How to Report an Adverse Drug Reaction
  • New Safety Information
    • Archive 2022
    • Archive 2021
    • Archive 2020
    • Archive 2019
    • Archive 2018
    • Archive 2017
    • Archive 2016
    • Archive 2015
    • Archive 2014
    • Archive 2013
    • Archive 2012
    • Archive 2011
    • Archive 2010
    • Archive 2009
  • Direct Healthcare Professional Communication
  • Risk minimisation measures (RMM)
  • List of serious adverse reactions
  • Information for Marketing Authorisation Holders
  • Adverse Drug Reactions Reports
  • Pandemic Influenza A/H1N1
  • Information for Marketing Authorisation Holders - Electronic Transmission of ICSRs
  • Seal for Marking of Important Safety Information
  • Pharmacovigilance and Risk Assessment Committee (PRAC) - Links
  • Medicinal Products under Additional Monitoring
  • Signal management
  • Submission of Application Documentation for Assessment of Non-Interventional Trials
  • SCOPE Project
  • Access to Databases of Suspected ADRs
  • Homepage
  • FAQ
  • Sitemap
  • Legal Notices
  • Contacts
  • About HALMED
  • Medicinal Products
  • Medical Devices
  • Distribution, Manufacturing and Inspection
  • Pharmacovigilance
  • News and Educations
  • HALMED for:
  • Patients and Public
  • Health Care Professionals
  • Industry Representatives

Copyright © 2007-2025. Agency for Medicinal Products and Medical Devices of Croatia.
All rights reserved.